However, there was only 63% agreement that BMI strongly influences treatment decisions regarding whether to prescribe SGLT2is versus GLP-1 RAs
L- : , , , , , 1
Realistic Expectation Setting: While AOD-9604 enhances metabolic function and fat oxidation, it is not a standalone solution for body composition change
PLoS ONE 11 (12), e0166913 (2016)
Advanced Delivery Systems To enhance penetration and efficacy, researchers are developing: Liposome-encapsulated GHK-Cu Nanoparticle delivery systems These technologies aim to deliver the peptide deeper into the dermis , improving clinical outcomes in both cosmetic and medical applications (Pickart & Margolina, 2018)
Poli V, Pui-Yan Ma V, Di Gioia M, Broggi A, Benamar M, Chen Q, et al